Vesicare
Vesicare

2.98
Used to address bladder and urinary conditions, this generic medicine reduces bladder muscle spasms to assist with control.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Solifenacin succinate
Reference Brand
Solifenacin
Product Origin
Generic Alternative
Reference Manufacturer
Astellas Pharma
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones
Product Category
Anticholinergic, Antispasmodic
Pharmacological Class
Muscarinic Antagonist
Clinical Indications
Manufacturer Description
Designed to support detrusor muscle relaxation to manage overactive bladder and alleviate frequency urgency.
Mechanism of Action
Selectively antagonizes muscarinic M3 receptors on the bladder detrusor muscle, blocking acetylcholine contractions.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Urinary retention, Gastric retention, Uncontrolled narrow-angle glaucoma, Severe hepatic impairment
Severe Adverse Events
Severe anaphylaxis — requires immediate medical attention, Angioedema — requires immediate medical attention
Common Side Effects
Dry mouth, Constipation, Dry eyes
Uncommon Side Effects
Blurred vision, Headache, Dyspepsia
Drug Interactions
Ketoconazole, Erythromycin, Anticholinergics
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for children over two years and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Vesicare is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to access Hair Regrowth Australia - Finasteride Male Pattern Baldness BPH